The Repurposing Drugs in Oncology DatabaseDrug repurposing is a drug development strategy predicated on the reuse of existing licensed drugs for new medical indications. Based on extensive literature research, the ReDO project has identified 268 licensed non-cancer drugs with published evidence of anticancer activity.
268
REDO DB
36%
32%
25%Europe
Asia
North America
6%Middle East
4%Oceania 8% other
190Aspirin 14%
Zoledronic Acid 11%Metformin 9%Vitamin D3 6%Celecoxib 6%
Olanzapine 5%
LATE STAGE ONCOLOGY TRIALS
Any questions? Please contact the ACF at [email protected]
DRUGS cheapGenericknown safety
cardiovascular
sensory organs
dermatologicals
anti-infectives
musculo-skeletal system
nervous system
genito-urinary system
hormonesalimentary tract
metabolism
anti-parasite insecticides
respiratory
blood
gastro-intestinalhematologicbreastLunggynaecologic
brain & CNS
paediatric
Recommended
